Recent Postings to

Worst Pills, Best Pills Newsletter Articles

  View the entire August 2018 issue in PDF format

  View the entire July 2018 issue in PDF format

  View the entire June 2018 issue in PDF format

  • Preventing Heat-Induced Death and Illness
    (June 2018)
    This article lists practical steps to take to avoid death, hospitalization or other medical problems caused by heat stress. It also identifies over 100 drugs that can impair your response to heat and thereby increase your risk of heat-induced illness and death.
  • FDA's "Breakthrough Therapies" Designation Often Misleading
    (June 2018)
    In his editor’s column, Dr. Michael Carome discusses an analysis by researchers at Harvard University that suggests that patients and doctors are being misled about the benefits of drugs approved under the FDA’s “breakthrough therapies” pathway.
  • Antibiotic Clarithromycin May Increase Risk of Death, FDA Warns
    (June 2018)
    Clarithromycin is an oral antibiotic that is commonly used to treat a wide range of bacterial infections. Learn why patients with heart disease should avoid this antibiotic unless no other suitable antibiotic is available.
  • Do Not Use the New Oral Blood Thinner Apixaban (ELIQUIS)
    (June 2018)
    Apixaban is a new oral anticoagulant (blood thinner) that was first approved by the FDA in 2012 for decreasing the risk of blood clots in certain patients. Find out why older anticoagulant drugs, such as warfarin (COUMADIN, JANTOVEN), are a better choice.
  • Topical Clobetasol Propionate: Only Use to Treat Severe Skin Disorders
    (June 2018)
    All but one of the clobetasol propionate products are classified as super-high potency topical corticosteroids. They are approximately 1,000 times more potent than over-the-counter 1-percent hydrocortisone. This article offers advice on how to use these products safely.

Additional Information from Public Citizen

Copyright © 2018 Public Citizen's Health Research Group. All rights reserved.